CEL is found in 4 entries

CEL as free ligands, exist in 4 entries. Examples include 1OQ5, 3KK6, 3LN1

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Identifiers 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
Formula C17 H14 F3 N3 O2 S
Molecular Weight 381.37 g/mol
Type non-polymer
Isomeric SMILES Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F
InChI InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)

Chemical Details

Formal Charge 0
Atom Count 40
Chiral Atom Count 0
Chiral Atoms
Bond Count 42
Aromatic Bond Count 19

Drug Info: DrugBank

DrugBank ID DB00482   (Stereoisomeric match)
Name Celecoxib
  • approved
  • investigational
Description Celecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer under the brand name Celebrex. In some countries, it is branded Celebra. Celecoxib is available by prescription in capsule form.
  • Celebrex
  • Celecoxib
  • Célécoxib
  • Celecoxibum
  • P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Brand Names
  • Accel-celecoxib
  • Act Celecoxib
  • Ag-celecoxib
  • Apo-celecoxib
  • Bio-celecoxib
  • Celebrex
  • Celecoxib
  • Gd-celecoxib
  • Ipg-celecoxib
  • Jamp-celecoxib
  • Lupin-celecoxib
  • Mar-celecoxib
  • Mint-celecoxib
  • Mylan-celecoxib
  • PMS-celecoxib
  • Priva-celecoxib
  • Ran-celecoxib
  • Rbx-celecoxib
  • Riva-celecox
  • Riva-celecoxib
  • Sandoz Celecoxib
  • Sdz Celecoxib
  • Teva-celecoxib
  • Articox
  • Articoxib
  • Artiflex
  • Artilog
  • Artix
  • Artrixib
  • Blockten
  • Caditar
  • Cefinix
  • Celact
  • Celebra
  • Onsenal
  • Valdyne
Affected Organism Humans and other mammals
Indication For relief and management of osteoarthritis (OA), rheumatoid arthritis (RA), juvenile rheumatoid arthritis (JRA), ankylosing spondylitis, acute pain, primary dysmenorrhea and oral adjunct to usual care for patients with familial adenomatous polyposis
Pharmacology Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is classified as a nonsteroidal anti-inflammatory drug (NSAID). Celecoxib is used to treat rheumatoid arthritis, osteoarthritis, and familial adenomatous polyposis (FAP). Because of its lack of platelet effects, celecoxib is not a substitute for aspirin for cardiovascular prophylaxis. It is not known if there are any effects of celecoxib on platelets that may contribute to the increased risk of serious cardiovascular thrombotic adverse events associated with the use of celecoxib. Inhibition of PGE2 synthesis may lead to sodium and water retention through increased fluid reabsorption in the renal medullary thick ascending loop of Henle and perhaps other segments of the distal nephron. In the collecting ducts, PGE2 appears to inhibit water reabsorption by counteracting the action of antidiuretic hormone.
Mechanism of action The mechanism of action of celecoxib is believed to be due to inhibition of prostaglandin synthesis. Unlike most NSAIDs, which inhibit both types of cyclooxygenases (COX-1 and COX-2), celecoxib is a selective noncompetitive inhibitor of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site. Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane.
Route of administration oral
  • L01XX33
  • M01AH01
AHFS-Code 28:08.04.08
CAS number 169590-42-5
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682